OSLO, NORWAY -- (Marketwire) -- 02/20/13 -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior management team will participate in the following upcoming investor conferences:

Citi Global Healthcare Conference 2013

Date: 25-27 February 2013

Participants:

Jeff Albers (President, Algeta US)

Mike Booth (IR)

Panel date & time: Tuesday 25 February, 2013, 10:20am EST

Venue: New York, NY, USA

Credit Suisse Global Healthcare One-on-One Conference

Date: 5-6 March 2013

Participants:

Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (IR)

Venue: London, UK

Carnegie Nordic Healthcare Seminar

Date: 12 March 2013

Participants:

Thomas Ramdahl (EVP & CTO)

Renate Birkeli (IR)

Presentation date & time: Tuesday 12 March, 2013, 10:05am CET

Venue: Stockholm, Sweden

Presentations, where applicable, will be available to download at www.algeta.com following these events.

###

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.

Press release:

http://hugin.info/134655/R/1679224/548304.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1679224]